Loading...
XJPX
6523
Market cap869mUSD
Dec 05, Last price  
1,068.00JPY
1D
2.01%
1Q
-3.96%
IPO
-60.30%
Name

PHC Holdings Corp

Chart & Performance

D1W1MN
XJPX:6523 chart
P/E
12.89
P/S
0.37
EPS
82.87
Div Yield, %
3.65%
Shrs. gr., 5y
0.77%
Rev. gr., 5y
5.81%
Revenues
361.59b
+2.17%
186,546,000,000272,637,000,000306,071,000,000340,452,000,000356,434,000,000353,900,000,000361,593,000,000
Net income
10.48b
P
15,453,000,0005,277,000,00016,906,000,000-8,460,000,000-3,221,000,000-12,892,000,00010,484,000,000
CFO
41.94b
+1.54%
33,790,000,00036,865,000,00047,850,000,00051,053,000,00021,376,000,00041,304,000,00041,941,000,000
Dividend
Mar 30, 202621 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

PHC Holdings Corporation, through its subsidiaries, develops, manufactures, and sells medical devices, healthcare technology solutions, and life science products. The company offers blood glucose monitoring systems and other testing/analysis devices, as well as data linkage solutions; anatomical pathology solutions, such as instruments, microscope slides, and dyeing reagents; and equipment and services for various sample preservation and cell culture in the life sciences field. It also provides healthcare IT products in the field of medical information systems for clinics and healthcare insurance pharmacies. In addition, the company engages in clinical testing, diagnostic reagents, and drug development support businesses. The company was formerly known as Panasonic Healthcare Holdings Co., Ltd. and changed its name to PHC Holdings Corporation in April 2018. The company was founded in 2014 and is headquartered in Tokyo, Japan.
IPO date
Oct 14, 2021
Employees
9,403
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT